EUROpean consortium for antiCALINs as next generation high-affinity protein therapeutics

Project Information

EUROCALIN

Grant agreement ID: 278408

Project closed

Start date 1 August 2011

End date 30 November 2015

Funded under

• Specific Programme "Cooperation": Health

Total cost € 8 730 394,21

EU contribution € 5 996 303,50

Coordinated by

PIERIS PHARMACEUTICALS GMBH
Germany